Panagora Asset Management Inc Arrowhead Pharmaceuticals, Inc. Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$27.21 - $39.48 $1.82 Million - $2.63 Million	-66,720 Reduced 78.25%	18,542 $530,000
Q4 2023 Feb 08, 2024	SELL	$21.2 - $31.03 $2.58 Million - $3.78 Million	-121,831 Reduced 58.83%	85,262 $2.61 Million
Q3 2023 Oct 31, 2023	SELL	$26.2 - $36.08 $1.22 Million - $1.68 Million	-46,529 Reduced 18.35%	207,093 $5.56 Million
Q2 2023 Aug 11, 2023	BUY	$25.16 - $41.38 $76,511 - $125,836	3,041 Added 1.21%	253,622 $9.04 Million
Q1 2023 May 11, 2023	BUY	$23.68 - $38.51 $108,454 - $176,375	4,580 Added 1.86%	250,581 $6.36 Million
Q4 2022 Feb 13, 2023	BUY	$28.0 - $40.56 $739,564 - $1.07 Million	26,413 Added 12.03%	246,001 $9.98 Million
Q3 2022 Nov 14, 2022	BUY	$29.63 - $48.31 $6.03 Million - $9.84 Million	203,593 Added 1272.85%	219,588 $7.26 Million
Q3 2021 Nov 10, 2021	SELL	$58.38 - $84.96 $105,784 - $153,947	-1,812 Reduced 10.18%	15,995 $999,000
Q2 2021 Aug 11, 2021	SELL	$62.15 - $90.32 $244,249 - $354,957	-3,930 Reduced 18.08%	17,807 $1.48 Million
Q3 2020 Nov 13, 2020	SELL	$33.21 - $51.27 $2.13 Million - $3.3 Million	-64,280 Reduced 74.73%	21,737 $936,000
Q2 2020 Aug 12, 2020	SELL	$26.12 - $43.27 $2.83 Million - $4.69 Million	-108,433 Reduced 55.76%	86,017 $3.72 Million
Q1 2020 May 14, 2020	SELL	$20.56 - $63.12 $1.74 Million - $5.34 Million	-84,640 Reduced 30.33%	194,450 $5.59 Million
Q4 2019 Feb 12, 2020	BUY	$28.14 - $73.01 $1.04 Million - $2.7 Million	36,915 Added 15.24%	279,090 $17.7 Million
Q3 2019 Nov 12, 2019	BUY	$26.26 - $34.86 $1.93 Million - $2.56 Million	73,345 Added 43.44%	242,175 $6.82 Million
Q2 2019 Aug 09, 2019	BUY	$17.43 - $28.82 $2.94 Million - $4.87 Million	168,830 New	168,830 $4.47 Million

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.01B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account